DNA Vaccine Market Size to Grow $774.43 Million, Globally, by 2030 at 6.3% CAGR: AMR

Rise in prevalence of cancer and infectious diseases in humans and animals and surge in the number of antibiotic-resistant pathogens drive the growth of the global DNA vaccine market

News provided by

Allied Market Research

Jan 18, 2022, 03:00 ET

PORTLAND, Ore., Jan. 18, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "DNA Vaccine Market by Product Type (Oncept, West Nile-Innovator, and Apex-IHN), Type (Therapeutic Vaccine, and Prophylactic Vaccines), and End User (Veterinary Clinics and Veterinary Hospitals): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global DNA vaccine industry generated $422.77 million in 2020, and is projected to reach $774.43 million by 2030, witnessing a CAGR of 6.3% from 2021 to 2030.

For Right Perspective and Competitive Insights, Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/671

Drivers, restraints, and opportunities

Rise in prevalence of cancer and infectious diseases in humans and animals and surge in the number of antibiotic-resistant pathogens drive the growth of the global DNA vaccine market. However, lack of immunogenicity associated with DNA vaccines and limited knowledge about the effects of DNA vaccines on humans hinder the market growth. On the other hand, development of novel vaccines using DNA technology creates new opportunities in the coming years.

Covid-19 Scenario

Owing to decline in number of visits and nationwide lockdowns, there has been an impact on the DNA vaccine market revenue. Moreover, there have been disruptions in development of DNA vaccines.
Changing the animal healthcare approach to provide care to emergency cases and critically ill animals also impacted the overall revenue.

The Oncept segment to continue its dominance during the forecast period

Based on product type, the Oncept segment contributed to the highest share in 2020, accounting for nearly half of the global DNA vaccine market, and is estimated to continue its dominance during the forecast period. This is due to rise in prevalence of canine melanoma cancer in animals, especially in dogs, which in turn, increased the demand for Oncept vaccine. However, the West Nile-Innovator segment is expected to witness the largest CAGR of 6.7% from 2021 to 2030.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/671

The veterinary hospitals segment to continue its leadership status during the forecast period

Based on end user, the veterinary hospitals segment accounted for the largest share in 2020, holding nearly three-fourths of the global DNA vaccine market, and is expected to continue its leadership status during the forecast period. This is due to increase in incidences of animal diseases, rise in hospital admissions of animals for vaccine dose, and availability of trained veterinarians in the hospitals. However, the veterinary clinics segment is estimated to manifest the highest CAGR of 6.6% from 2021 to 2030, owing to rise in the number of veterinary clinics due to growth in ownership of companion animals as well as the availability of trained and licensed veterinarians in clinics.

The U.S. to continue its lead position in terms of revenue by 2030

Based on region, the U.S. held the highest market share in 2020, accounting for nearly 88% of the global DNA vaccine market, and is expected to continue its lead position in terms of revenue by 2030. This is due to presence of major key players, well-established healthcare infrastructure, high purchasing power, and higher healthcare expenditure levels. However, Canada is expected to portray the fastest CAGR of 7.1% during the forecast period, owing to product approvals in the country and presence of well-established healthcare infrastructure.

Leading Market Players

Boehringer Ingelheim GmbH
Eli-Lilly (Novartis Animal Health)
GeneOne Life Science
Geovax Labs, Inc.
Inovio Pharmaceuticals (VGX Animal Health)
Genexine, Inc.
Viatris Inc. (Rottapharm Biotech)
Takara Holdings (Takara Bio)
Zoetis Inc. (Fort dodge Animal Health)
Zydus Cadila

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Cancer Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Animal Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

BCG Vaccine Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Therapeutic Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Meningococcal Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Paediatric Vaccine Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Vaccine Adjuvants Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Rabies Vaccine Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/